PerkinElmer to collaborate on discovery of biomarkers in cancer laboratories

By Lisa Kerner

Charlotte, N.C., July 24 - PerkinElmer, Inc. said it entered into two multi-year research collaboration agreements with Johns Hopkins University and the University of Birmingham, United Kingdom, leading to the discovery of biomarkers in cancer laboratories.

These collaborations are designed to drive the emerging field of proteomics, developing new technologies for clinical research, according to a company news release.

The PerkinElmer BioExpression Platform's carrier protein-based biomarker enrichment technology is a new method in finding low-abundance disease-related biomarkers.

"Working in partnership with premier research institutions like Johns Hopkins and the University of Birmingham represents an outstanding opportunity for PerkinElmer to strengthen collaborations with scientific leaders in biomarker discovery and at the same time gather important input on our technologies," said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences, in the release.

Boston-based PerkinElmer is a global technology company specializing in health sciences and photonics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.